Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

US Patent 8227417 · Granted Jul 24, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for generating a reference trajectory within a lane, method for operating2025
Human monoclonal antibody targeting TNFR2 for cancer immunotherapy2022
Human monoclonal antibody targeting TNFR2 for cancer immunotherapy2022
Therapeutic antitumor combination of a TLR4 ligand with other treatments2022
Therapeutic antitumor combination of a TLR4 ligand with other treatments2022
Therapeutic antitumor combination of a TLR4 ligand with other treatments2022
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressant2017
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressant2017
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressant2017
Primary zinc-air battery2007
Easy refuelling metal-gas cell battery with soft pocket2005
T20/DP178 is an activator of human phagocyte formyl peptide receptors2004